APOA1 and cardiac amyloidosis: A164S, a variant without any association with HDL cholesterol or apoA-I levels in the CCHS and CGPS, was associated with an increased risk of IHD, MI, and premature death, and with reduced survival after diagnosis of IHD in the CCHS, most likely due to an attenuated form of cardiac amyloidosis [13].